We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Lassa virus causes Lassa fever, an acute viral haemorrhagic fever (VHF).
Crimean-Congo haemorrhagic fever (CCHF) is a viral haemorrhagic fever (VHF) caused by a virus of the Nairoviridae family.
Examples of viral haemorrhagic fevers (VHFs) include Lassa fever, Crimean-Congo haemorrhagic fever, Marburg and Ebola virus diseases.
The characteristics, diagnosis, treatment, and epidemiology of group B streptococci.
PGD template for administering hexavalent vaccine following national recommendations and the routine childhood immunisation programme.
Patient group direction (PGD) template for administering inactivated influenza vaccine in accordance with national seasonal flu vaccination programme.
Information on Bartonella and how to obtain diagnostic services.
Advice on the recognition, investigation and management of Panton-Valentine Leukocidin (PVL)-Staphylococcus aureus (PVL-SA) cases.
Guidance to help professionals in public health and environmental health departments to minimise the risk of transmission of gastrointestinal infections.
This leaflet can help GPs and nurses talk about TB with their patients. Available in English and 11 other languages.
PGD template to support the national meningococcal group B (Bexsero®) vaccination programme and public health management of meningococcal disease.
Guidance for people who have been diagnosed with mpox or who are waiting for an mpox test result and have been advised to self-isolate at home
Guidance for healthcare practitioners about the coronavirus (COVID-19) vaccination programme.
This explains the importance of the influenza (flu) vaccination this winter: 2025 to 2026.
Information for healthcare professionals on the diagnosis, prevention and treatment of hepatitis B.
Information about incidents and outbreaks of Ebola and Marburg, both viral haemorrhagic fevers (VHF).
This page provides an overview of mpox epidemiology, indicating where there may be a risk of clade I and clade II mpox exposure.
Information and promotional resources to support the 2025 to 2026 annual flu vaccination programme.
Guidance on sexual transmission of Zika virus and methods of prevention.
Materials to advise those travelling abroad on reducing the risk of acquiring mosquito-borne infections.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).